129 stories from 18 sources
The week in Medicine and Healthcare
Click on a headline to see stories that shaped it.
Threads
8 threads
The outbreak crossed 3,000 deaths as unpaid workers closed checkpoints and funding shortages threatened treatment, testing, and vaccination. Roche’s planned equipment deployment could improve local testing, but only if authorities can staff laboratories and move samples safely.
The administration added nine drug-pricing agreements, extending an earlier push to lower prescription costs. Follow-up questions focused on which medicines are covered, how savings reach patients, and whether the deals could undermine broader cost-control efforts.
After 11 deaths in New York, hearings and competing proposals shifted attention toward staffing, cooling-tower monitoring, and clear responsibility for prevention. The outbreak became a test of whether building-linked disease risks can be detected before another fatal event.
OpenAI connected ChatGPT for Healthcare to read-only Epic records, bringing generative AI closer to clinical workflows. The FDA then accepted four generative AI devices into supervised real-world testing, increasing the need for performance standards, privacy controls, and accountability.
Eli Lilly agreed to buy Merida Biosciences for up to $2.88 billion, adding autoimmune and allergy assets. The acquisition extends Lilly’s effort to use its metabolic-drug strength to replenish and diversify its pipeline.
A suspected food-poisoning event first hospitalized more than 500 students, then expanded to about 2,000 people. The widening toll put procurement, food handling, oversight, and the free school-meals program’s expansion under pressure.
Reports across the week showed that Medicare Advantage patients who develop Alzheimer’s or other serious illnesses may switch plans but face narrower networks, prior authorization, and higher costs. The decisions can disrupt both finances and clinical care.
Doctors’ groups issued vaccination guidance ahead of respiratory illness season, with later guidance urging vaccination against flu, COVID, and RSV. The recurring recommendations put seasonal prevention back into focus as the next respiratory season approached.
Day’s Recap